Brian Prew

• Neurocrine Biosciences Inc. v. Teva Pharmaceuticals USA, Inc.: Representing Teva in its Paragraph IV challenge to Neurocrine’s patents in the District of Delaware relating to a generic version of Ingrezza®.
• Certain Nicotine Pouches and Components Thereof and Methods of Making the Same; Inv. No. 337-TA-1192: Represented several foreign manufacturers and U.S. distributors in an ITC investigation involving alleged patent infringement of popular nicotine cessation products. Positioned the case for early summary determination, resulting in Complainant moving to withdraw the complaint just three months after institution and on the eve of claim construction.
• Swedish Match North America LLC, et al. Kretek International, Inc. et al. (C.D.Ca.): Represented several foreign manufacturers and U.S. distributors in the Central District of California involving alleged patent infringement of popular nicotine cessation products. Successfully moved to dismiss the foreign manufacturers for lack of jurisdiction and obtained a dispositive claim construction, resulting in a judgment of non-infringement. This case is pending appeal at the Federal Circuit.
• Certain Filament Light-Emitting Diodes and Products Containing Same (II); Inv. No. 337-TA-1220: Representing Satco in the defense of a suit brought at the International Trade Commission by complainant, the Regents of the University of California at Santa Barbara, over four patents relating to LEDs. The trial was conducted from Aug. 30-Sept. 3, 2021. Also serving as counsel in parallel district court litigations on the same patents which have been stayed pending the resolution of the ITC investigation.
• Satco Products, Inc. v. The Regents of the University of California: Representing petitioner Satco in four inter partes review proceedings before the PTAB against The Regents of the University of California at Santa Barbara (UCSB) relating to LEDs. Invalidated all claims of four patents which had been asserted by UCSB.
• Certain Strontium-Rubidium Radioisotope Infusion Systems, and Components thereof Including Generators, ITC Inv. No. 337-TA-1110: Representing client in on-going Section 337 Investigation.
• Chiesi U.S.A., Inc. et al. v. Teva Pharmaceuticals USA, Inc. (D. Del.): Represented Teva in the Paragraph IV ANDA challenge of patents relating to Bethkis® (tobramycin inhalation solution) indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa.
• Sanofi-Aventis U.S. LLC et al. v. Fresenius Kabi USA, LLC et al. (D.N.J.): Represented Fresenius Kabi and Actavis in a patent litigation involving Sanofi’s branded cancer drug Jevtana^® (cabazitaxel).°
• Hospira, Inc., et al. v. West-Ward Pharmaceuticals Corp., et al. (D. Del.): Represented West-Ward in ANDA case concerning the administration of Hospira’s Precedex^® (dexmedetomidine hydrochloride).°
• Eli Lilly and Co., et al. v. Teva Parenteral Medicines, Inc., et al. (S.D. Ind.): Represented Teva and Fresenius in ANDA case concerning the administration of Eli Lilly’s Alimta^® (pemetrexed disodium).°
• Teva Branded Pharmaceutical Products R&D Inc., et al. v. Perrigo Pharmaceuticals Co., et al. (D. Del.): Represented Teva in a case concerning ProAir^® HFA (albuterol sulfate inhalation aerosol).°
• Apotex Inc., et al. v. Teva Pharmaceutical Industries Ltd. et al. (S.D. Fl.): Represented Teva in case concerning the process for manufacturing quinapril hydrochloride.°
• comScore, Inc. v. DoubleVerify Inc. (E.D. Va.): Represented DoubleVerify in a case concerning technology for tracking the display of internet content.°
• Research Affiliates, LLC v. WisdomTree Investments, Inc., et al. (C.D. Cal.): Represented WisdomTree in patent case concerning exchange traded funds (ETFs).°
• Pfizer Inc., et al. v. Teva Pharmaceuticals USA, Inc., (E.D. Va.): Represented Teva in an ANDA case concerning Pfizer’s drug Viagra^® (sildenafil citrate tablets).°
• Chicago Board Options Exchange v. International Securities Exchange, (N.D. Ill.). Represented International Securities Exchange in a patent infringement case involving a system for trading financial instruments.°
• Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc., (D. Del.): Represented Teva in an ANDA case concerning Pronova’s drug Lovaza^® (omega-3 acid ethyl ester capsules).°
• Teva Pharmaceuticals USA, Inc. v. Amgen Inc., (E.D. Pa.): Represented Teva in an action against Amgen concerning Amgen’s product, Neupogen^® (human granulocyte colony-stimulating factor).°

°The above representations were handled by Mr. Prew prior to his joining Greenberg Traurig, LLP.

• Naval Sea Systems Command (NAVSEA)
  • Chemical Engineer, Energy Conversion R&D, 2000-2008

• Judicial Intern to the Honorable Joseph H. Rodriguez, U.S. District Court for the District of New Jersey, 2006-2007

• Listed, The Legal 500 United States, Intellectual Property - Patents: Litigation (International Trade Commission), 2024
• Listed, Intellectual Asset Management (IAM) magazine, "IAM Patent 1000," 2024
• Listed, Super Lawyers magazine, New York Metro Rising Stars, 2016-2018

A description of the selection methodology for the above awards can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

• Member, New York Intellectual Property Law Association (NYIPLA)
  • Co-Chair, Inventor of the Year (IOTY) Committee, 2017-2021